Trademark: 79222834
Word
CAELUS PHARMACEUTICALS
Status Date
Tuesday, December 4, 2018
Registration Number
5619593
Registration Date
Tuesday, December 4, 2018
Filing Date
Thursday, June 1, 2017
Published for Opposition
Tuesday, September 18, 2018
5 Pharmaceutical products for treating cardiometabolic disorders; dietetic foodstuffs adapted for medical use and dietetic substances, namely, dietetic foods adapted for medical use; food supplements for human beings; medical preparations and articles for the treatment of cardiometabolic disorders; diagnostic preparations for medical use; pharmaceutical products and natural medicines, both for the treatment of cardiometabolic disorders; vaccines; pharmaceutical preparations, namely, medicines and vaccines, for the prevention of diabetes mellitus, Crohn's disease and ulcerative colitis disease; pharmaceutical preparations, namely, medicines for the treatment of diabetes mellitus, Crohn's disease, ulcerative colitis disease and metabolic syndrome being insulin resistance; dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic preparations, namely, dietary supplements; dietary food preparations, namely, dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the prevention of diabetes mellitus, Crohn's disease and ulcerative colitis disease; dietary food preparations, namely, dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the treatment of diabetes mellitus, Crohn's disease, ulcerative colitis disease and metabolic syndrome being insulin resistance; medical preparations, namely, cultures of microorganisms for medical use, and bacterial preparations for medical use; chemicals for the diagnosis of diabetes mellitus, Crohn's disease and ulcerative colitis disease; vaccine preparations for human use
10 Medical apparatus and instruments, namely, for use in treating cardiovascular disease or diabetes, for monitoring vital signs, blood sugar levels, AGE-levels in the skin and gut/skin microbiota composition; Medical diagnostic, testing and monitoring equipment, namely, medical diagnostic equipment for detecting and monitoring blood sugar levels, AGEs and microbiome composition; testing apparatus for medical use, namely, medical devices for testing blood glucose, microbiome composition in gut and on the skin, testing AGE-levels, and for testing the levels of butyrate in breath analysis; measuring devices for medical use, namely, medical device for measuring glucose, insulin, butyrate, propionate, gut and skin microbiome; testing apparatus for medical use, namely, blood testing apparatus, apparatus for analyzing feces or respiratory gas, medical measuring devices for medical use, namely, devices for measuring microorganisms or gas; medical test kits for home monitoring of diabetes
Dec 30, 2023
New Representative At Ib Received
Dec 4, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 5, 2019
Final Decision Transaction Processed By Ib
Mar 18, 2019
Final Disposition Notice Sent To Ib
Mar 18, 2019
Final Disposition Processed
Mar 4, 2019
Final Disposition Notice Created, To Be Sent To Ib
Dec 4, 2018
Registered-Principal Register
Sep 18, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 18, 2018
Published For Opposition
Sep 15, 2018
Notification Processed By Ib
Aug 29, 2018
Notification Of Possible Opposition Sent To Ib
Aug 29, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 29, 2018
Notification Of Notice Of Publication E-Mailed
Aug 13, 2018
Assigned To Lie
Aug 2, 2018
Approved For Pub - Principal Register
Aug 2, 2018
Examiner's Amendment Entered
Aug 2, 2018
Notification Of Examiners Amendment E-Mailed
Aug 2, 2018
Examiners Amendment E-Mailed
Aug 2, 2018
Examiners Amendment -Written
Jul 6, 2018
Teas/Email Correspondence Entered
Jul 6, 2018
Correspondence Received In Law Office
Jul 6, 2018
Teas Response To Office Action Received
Feb 16, 2018
Refusal Processed By Ib
Feb 15, 2018
New Representative At Ib Received
Jan 12, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Jan 12, 2018
Refusal Processed By Mpu
Dec 23, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Dec 23, 2017
Application Filing Receipt Mailed
Dec 22, 2017
Non-Final Action Written
Dec 19, 2017
Assigned To Examiner
Dec 19, 2017
New Application Office Supplied Data Entered
Dec 18, 2017
Limitation From Original Application Entered
Dec 14, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
